New 13G (. Late Friday evening )
$Inhibikase Therapeutics (IKT.US)$ 10.95 Million shares ((((. Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sands Capital Life Sciences Pulse Fund II, L.P.(16.3%),Sands Capital Ventures, LLC(16.3%), etc.
SEC· Oct 25 17:52 )))
SEC· Oct 25 17:52 )))
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
